TrialAlzheimer's research & therapy2016

Long-term safety and tolerability of bapineuzumab in patients with Alzheimer's disease in two phase 3 extension studies.

Adrian Ivanoiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.